Indegene analyst recommendations
Motilal Oswal upgraded Indegene and set a target price of ₹708, citing demand for outsourced services and its role with life sciences clients. Axis Direct initiated coverage with a buy recommendation and indicated 18% upside.
Timeline
Friday, 25 September
- Indegene share price jumps 5% to hit a 52-week high after Axis initiates coverage with a buy - Check target price
Axis Direct initiated coverage with a buy recommendation and suggested 18% upside
- Motilal Oswal upgrades Indegene and sets ₹708 target
Motilal Oswal said rising outsourced-services demand could benefit Indegene
